Prevalence, outcomes, and cost of chronic kidney disease in a contemporary population of 2·4 million patients from 11 countries: The CaReMe CKD study

BACKGROUND: Digital healthcare systems data could provide insights into the global prevalence of chronic kidney disease (CKD). We designed the CaReMe CKD study to estimate the prevalence, key clinical adverse outcomes and costs of CKD across 11 countries. METHODS: Individual-level data of a cohort o...

Descripción completa

Detalles Bibliográficos
Autores principales: Sundström, Johan, Bodegard, Johan, Bollmann, Andreas, Vervloet, Marc G., Mark, Patrick B., Karasik, Avraham, Taveira-Gomes, Tiago, Botana, Manuel, Birkeland, Kåre I., Thuresson, Marcus, Jäger, Levy, Sood, Manish M., VanPottelbergh, Gijs, Tangri, Navdeep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459126/
https://www.ncbi.nlm.nih.gov/pubmed/36090671
http://dx.doi.org/10.1016/j.lanepe.2022.100438

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459126/
https://www.ncbi.nlm.nih.gov/pubmed/36090671
http://dx.doi.org/10.1016/j.lanepe.2022.100438

Ejemplares similares